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ABSTRACT 
Purpose: Radiation-induced dermatitis is a common side effect of breast radiotherapy (RT). 
Current methods to evaluate breast skin toxicity include clinical examination, visual inspection, 
and patient-reported symptoms. Physiological changes associated with radiation- induced 
dermatitis, such as inflammation, may also increase body-surface temperature which can be 
detected by thermal imaging. Quantitative thermal imaging markers were identified using 
supervised machine-learning to develop a predictive model for radiation dermatitis. 
Methods: Ninety patients treated for adjuvant whole-breast radiotherapy (4250 Gy/fx=16) were 
recruited to the study. Thermal images of the treated breast were taken at four intervals: prior to 
RT, then weekly, at fx=5, fx=10, and fx=15. Parametric thermograms were analyzed and yielded 
26 thermal-based features which included surface temperature (C) and texture parameters 
obtained from 1) grey-level co-occurrence matrix (GLCM), 2) grey-level run-length matrix 
(GLRLM) and 3) neighborhood grey-tone difference matrix (GTDM). Skin toxicity was 
evaluated at the end of RT using the Common Terminology Criteria for Adverse Events 
(CTCAE) guidelines (Ver.5). Binary group classes were labelled according to a CTCAE cut-off 
score of ≥2, and thermal features obtained at fx=5 were used for supervised machine learning to 
predict skin toxicity. The dataset was partitioned for model training, independent testing, and 
validation. Fifteen patients (~ 17% of the whole dataset) were randomly selected as an unseen 
test dataset, and 75 patients (~ 83% of the whole dataset) were used for training and validation of 
the model. A random forest classifier with leave-one-patient-out cross-validation was employed 
for modelling single and hybrid parameters. The model performance was reported using receiver 
operating characteristic analysis on patients from an independent test set.  
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Results: Thirty-seven patients presented with adverse skin effects, denoted by a CTCAE score 
≥2, and had significantly higher local increases in skin temperature, reaching 36.06C at fx=10 
(p=0.029). However, machine- learning models demonstrated early thermal signals associated 
with skin toxicity after the fifth RT fraction. The cross-validated model showed high prediction 
accuracy (Acc) on the independent test data (test Acc=0.87) at fx=5 for predicting the skin 
toxicity at the end of RT.  
Conclusion: Early thermal markers after five fractions of RT are predictive of radiation- induced 
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INTRODUCTION 
Radiation therapy (RT) utilizes ionizing radiation to target residual cancer cells of the 
breast and induce cellular death. This results in the reduction of locoregional and distant cancer 
recurrence following lumpectomy (15.7%; 95% CI: 13.7-17.7; p<0.00001) (1) or mastectomy 
(11.5%; 95% CI: 0.57-0.82; p=0.00006) (2). However, RT is associated with dermatological 
risks such as erythema which affects approximately 90% of treated patients (3,4). The skin is a 
highly proliferative organ and is therefore, susceptible to radiation damage and toxicity (5). 
Cellular apoptotic and necrotic events are initiated in the skin from repeated and fractionated 
exposure to radiation (5,6). Cellular death leads to the recruitment of cytokines, prompting an 
inflammatory response (acute dermatitis) that stimulates the transendothelial migration of 
immune cells to the target site (5,6). Consequently, blood vessels dilate causing increases in 
blood volume; while the damaged irradiated skin clinically presents as erythema and 
desquamation (3). As a result, patients undergoing RT are carefully monitored using standard 
assessment tools such as, the Common Terminology Criteria for Adverse Events (CTCAE) 
system to manage toxicity burden (7). Major challenges associated with visual inspection of the 
breast to evaluate skin-related symptoms include low sensitivity and specificity for detecting 
early signs of dermatitis, as well as differentiating the degree of severe skin toxicity (i.e. 
CTCAE≥2). This is caused by practitioner bias, under-reporting by patients, and clinician 
expertise that may lead to the variabilities in grading skin toxicity (7–9). Topographical imaging 
modalities, such as quantitative thermal imaging (QTI) have the potential to overcome these 
challenges and objectively measure the changes in surface skin temperature associated with 
radiation- induced skin dermatitis. Exploiting QTI and machine learning frameworks (i.e. 
thermoradiomics) may yield actionable insight into symptom management during radiotherapy. 
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 Quantitative thermal imaging has previously been used to identify temperature changes 
associated with alterations in blood flow and disease presentation (10–12). Within the RT 
setting, Maillot et al., investigated the use of thermography to quantitatively evaluate skin 
toxicity and found that patients that were classified using the CTCAE, and Radiotherapy 
Oncology Group (RTOG) criteria, demonstrated a high grade of skin toxicity (≥2) that was also 
associated with an increase in the average local temperature (p<0.05) (13). Furthermore, Maillot, 
et al. found that thermography-derived temperature features recorded a week before the clinical 
presentation of skin toxicity, had a predictive value of 70%. Their study also demonstrated a 
higher incidence of high-grade radiation- induced dermatitis after 10 – 15 RT fractions (13). 
Other QTI applications for breast cancer include using first-order temperature features, and 
second-order features such as thermogram-texture parameters for detecting breast lesions. 
Milosevic et al. tested the feasibility of thermal breast imaging to screen for malignancies. The 
study exploited machine learning classification algorithms to distinguish thermal features 
associated with benign versus malignant masses in the breast. Second-order features included 
grey-level co-occurrence matrix (GLCM) features, and the results of the study demonstrated a 
diagnostic accuracy of 92.5% (14). Potential applications and advantages of employing image-
guided decision support tools, such as QTI include early-intervention and preventive therapeutics 
that could mitigate radiation- induced skin toxicity. Current treatment strategies for managing 
skin toxicity include the use of glucocorticosteroids, to inhibit the inflammatory response that 
mediates acute skin dermatitis (15,16). Early thermoradiomic markers for skin toxicity would 
potentially allow radiation oncologists to target patients for prophylactic corticosteroid use, 
which has been shown to reduce the incidence of radiation-induced dermatitis (17).  
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Although the capability of thermal imaging to monitor the occurrence of disease has been 
demonstrated in previous studies, the potential of using temperature-based, and textural features 
as imaging biomarkers for radiation- induced dermatitis remains unclear and warrants further 
investigation (12,13). Here, we investigated QTI and machine learning frameworks (i.e. 
thermoradiomics) to develop a predictive tool for radiation-induced skin toxicity at early 
treatment time intervals. This study aimed to measure thermal characteristics of the irradiated 
skin in breast cancer patients and we hypothesized that radiation- induced skin toxicity is 
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METHODS 
Patient Recruitment Criteria and Radiation Treatment Parameters 
This study was carried out at a single academic health centre and approved by the 
institutional research ethics board. Participants signed an informed consent form prior to 
enrolment. Patients were included in the study based on the following inclusion criteria: 
confirmed diagnosis of invasive breast cancer or ductal carcinoma in situ, age (18+), and 
undergoing adjuvant hypofractionated radiotherapy to the whole breast or chestwall (4250 
Gy/fx=16). Patients were excluded from the study if their planned treatment position was prone, 
undergoing expander-implant breast reconstruction, or had a history of inflammatory breast 
cancer (18,19). Ninety patients were prospectively recruited to the study and clinical 
characteristics are presented in Table 1. All patients completed a full whole-breast or chestwall 
treatment course, i.e. 16 fractions of adjuvant RT and received standard skin management 
strategies, consisting of saline rinses only. As part of the study protocol, patients were not 
prescribed topical corticosteroids (e.g. hydrocortisone) or topical antibiotics (e.g. 
Bacitracin/polymyxin B or silver sulfadiazine cream) during their treatment course. Figure 1 
summarizes the study workflow and methods.  
 
Data Acquisition: Quantitative Thermal Imaging and Clinical Information 
Infrared (IR, thermal) imaging data was captured using a Forward-Looking Infrared 
(FLIR) E53 Advanced Thermal Imaging Device (FLIR, Wilsonville, USA). Images were 
acquired from the ipsilateral and contralateral breasts at the following time intervals: baseline 
(prior to RT), and after every fifth RT fraction (fx=5, fx=10, and fx=15). Imaging settings were 
kept constant throughout the time series for each patient. A fixed distance of 2 m was used 
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between the patient and camera. Thermograms were reconstructed at a resolution of 240 x180 
pixels. The instantaneous field of view (IFOV), which comprises the pixel size on the 
measurement surface (i.e. breast or chestwall) was 3.54 mm. Thermal images were captured 
using a fixed emissivity setting of =0.98.  
Long wave infrared thermography was carried out in a designated exam room. The room 
was controlled for ambient temperature and air flow during examination. Patients were 
positioned, while standing, with their arm behind their head, exposing the axilla, midline, and 
inframammary folds. All study participants were evaluated for radiation- induced skin toxicity 
using the CTCAE Ver. 5 guidelines and information was recorded in the electronic medical 
record. The final CTCAE assessment (i.e. end of the 16th fraction) was used for ground truth 
labelling in machine learning models (described below). Other clinical and demographic 
information were collected from the electronic medical records, and included the following 
variables: age, cancer diagnosis, clinicopathological characteristics of the tumor, surgery details 
and radiotherapy treatment information. Patient ethnicity was collected through clinical reports 
and breast cup size was measured as per the standardized North American scale (Table 1).  
Other clinical information associated with risk factors for radiation-induced dermatitis 
were collected from the patients’ electronic medical record and recorded in the patients’ case 
report forms (CRFs). Table 1 includes information on those variables, which include the 
administration of adjuvant chemotherapy (y/n), type of adjuvant chemotherapy, local treatment 
(whole breast only) versus locoregional irradiation (four-field technique involving the chestwall 
and regional lymph nodes), the radiation dose to skin volume (cGy), and menopausal status (20–
22).  
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Image Processing and Feature Extraction  
Data preprocessing was performed to construct parametric thermal images using FLIR’s 
proprietary software development kit (FileReader; FLIR, Wilsonville, USA). Thermal images 
were normalized using the software development kit prior to segmentation and analysis, which 
used a non-uniformity correction (NUC) process. Analytical software for segmentation and to 
extract first and second order QTI features was developed using MATLAB (The MathWorks, 
Natick USA). The region of interest (ROI) was delineated manually by using a standard protocol. 
The ROI comprised the treatment field borders according to clinical and anatomical landmarks, 
i.e. clavicle (superior border), 2 cm below inframammary fold (inferior border), midline sternum 
(medial border) and mid-axillary line (lateral border). The radiation treatment field published 
from the radiation treatment planning system (Pinnacle, Philips Healthcare, Amsterdam 
Netherlands) was used as a reference to the targeted irradiated area of the thermograms for each 
time interval. All ROIs were verified with our collaborating radiation oncologists with 5-30 years 
of experience (Figure 2F).  
First-order features included temperature (°C) measurements, which were calculated as 
an average value across the entire breast treatment area (Figure 2C). Other first-order features 
included entropy, skewness and kurtosis. All first-order features recorded are presented in 
Supplementary Table 1. The thermal images were also analyzed using second-order statistics to 
extract 25 textural features related to Haralick textures. For extracting textural features from the 
thermal images, the original thermograms were used without resampling and the full range of 
gray-level intensities in each thermal image was quantized into 16-levels. Second-order texture 
features were extracted using MATLAB (The MathWorks, Natick USA), and adapted from 
open-source radiomics codes using the Pyradiomics platform (23,24). The Pyradiomics platform 
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has been used in previous radiomic studies, and comprise standard methods for radiomics feature 
extraction and image analysis (24). Second-order features were derived using a grey-level co-
occurrence matrix (GLCM), which yielded attributes associated with the spatial relationship 
between pixel intensities (25,26). Other second-order features were computed from a grey-level 
run-length matrix (GLRLM) and a grey-tone difference matrix (GTDM). Other available second-
order feature matrices (e.g. a grey-level size zone [GLSZM] and a grey-level dependence matrix 
[GLDM]) were excluded due to redundancy with the selected feature sets, and sample size 
limitations, i.e., to avoid “data fishing” that can potentially overfit the models (i.e. the total 
number of selected features within a given model should be limited to 1/10 of the sample size) 
(27,28).  
Overall, there were four Haralick texture GLCM features (FGLCM=4), five GTDM 
features (FGTDM=5) , and 16 GLRLM attributes (FGLRLM=16). Grey-tone texture features were 
calculated based on a grey-scale of 16-tones (Ng=16). The displacement vector (d) and offset 
angle (), relative to the central pixel was constrained to, d=1, and  = 0, 45, 90, 135, 
respectively. Directional matrices (GLCM and GLRLM) were summated into a global matrix 
and normalized prior to feature extraction. The texture equations (GLCM, GTDM, GLRLM) and 
the textural features (F=25) are described in Supplementary Tables 2, 3 and 4.  
 
Statistical Analysis 
  Descriptive statistics were calculated for differences in temperature and textural features 
between CTCAE≥2 and CTCAE≤1 patient classes using SPSS V. 24 (IBM Corp., Armonk, NY, 
USA). This was calculated for the ipsilateral (irradiated) side and contralatera l (non-irradiated) 
side. A Shapiro-Wilk test was used to test for normality violations. Averages were calculated 
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(Figure 2C) and compared between groups using both parametric (unpaired, 2-sided 
independent t-test) and non-parametric (Mann-Whitney) statistical tests based on normal versus 
non-normal data distributions, respectively. A repeated-measures analysis of variance (ANOVA) 
was carried out to determine the significance of temporal changes in features. A Bonferroni 
correction for multiple comparisons was carried out, as well as random sampling with 
replacement (i.e. bootstrapping) over 1000 repetitions. Group comparisons for clinical and 
demographic data used a Fisher’s exact test to compare categorical variables (Table 1). P values 
< 0.05 were considered significant. 
 
Dimensionality Reduction and Machine Learning Modelling 
For thermoradiomic markers, the relative changes from the baseline value of all first- and 
second-order features were calculated for each subject and class at all time intervals. Skin 
toxicity is typically observed after the 10th RT fraction; therefore, the objective was to test if QTI 
and texture parameters obtained from earlier time intervals (i.e., 5th RT fraction) demonstrated 
early prediction capabilities to severe skin toxicity.  Several machine learning classification 
experiments were carried out to yield various predictive models.  First, the dataset was divided 
into two sets for training and independent testing of the model. Fifteen patients (~ 17% of the 
whole dataset) were randomly selected as an unseen test dataset, and 75 patients (~ 83% of the 
whole dataset) were used for training and validation of the model. Feature selection was 
performed using a sequential forward feature selection (SFS) approach. The leave-one-patient-
out (LOPO) cross-validated area under the receiver operating characteristic (ROC) curve (area 
under the curve, AUC) was used as the criteria for feature selection. In the first two experiments, 
the first-order temperature features alone, were used as the initial feature set. In experiments 
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three and four, all first-order and texture features were included in the initial feature set.  Since 
the first initial feature set only included 8 first-order features, no feature reduction was applied or 
required prior to feature selection. The second initial feature set included 33 features (8 first-
order and 25 texture features) and the redundant features were eliminated based on inter-feature 
correlation. Specifically, the correlation between each two features was calculated. The features 
with high inter-feature correlation (r2 > 0.70) were selected for analysis, and the retention 
criterion was based on the feature that yielded a higher AUC in the training set. Bootstrapping 
was used on the training data to improve the generalization performance of the trained classifier 
on unseen data (29). Specifically, the classifier was trained using 100 bootstrap samples for each 
fold of the data during LOPO cross-validation. Before each bootstrap sampling, the majority 
class (negative) was randomly down sampled to compensate for the imbalance of data between 
the two classes (45 negative versus 30 positive cases). The optimal feature set was selected using 
a majority vote on the selected features for all folds of the data. The sensitivity, specificity, and 
accuracy of the trained model were calculated on the unseen test data and used in addition to the 
AUC to evaluate the efficacy of the optimal feature set to predict skin toxicity (30).  
Machine learning classification experiments were repeated using clinical features alone to 
develop a baseline clinical model. Six clinical features were modelled, which have been 
previously shown to predict radiation- induced skin toxicity: adjuvant chemotherapy (y/n), type 
of adjuvant chemotherapy, local (whole breast only) versus locoregional (four-field technique) 
irradiation, radiation dose to skin volume (cGy), menopausal status, and cup size. The clinical 
model was trained and subsequently evaluated using the same training and testing sets (subjects) 
that were utilized to develop the thermoradiomic model. The baseline clinical model was used to 
compare the performances between clinical features alone, versus thermoradiomic predictors.  
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RESULTS 
Study Participant Demographics and Outcomes 
Of the ninety patients enrolled in this study, 37 (41%) presented with bright tender 
erythema and/or desquamation (CTCAE≥2) at the end of their treatment. The difference in 
reported skin toxicity between CTCAE≥2 and CTCAE≤1 groups is represented in 
Supplementary Figure A. Of the patients that presented with skin toxicity (CTCAE≥2), 70.3% 
were Caucasian, 13.5% Asian, and 5.4% were Black (Table 1). Further demographic and clinical 
features such as cancer histological type, tumor grade, and molecular subtype are presented in 
Table 1.  
 
Temperature Measurements of the Treated Breast 
Significant differences (p<0.05) in skin-surface temperatures (mean value and central 
tendency measures) were observed between the CTCAE≥2 and CTCAE≤1 classes, at fraction 
intervals fx=10 and fx=15 (Figure 3A, Supplementary Figure B). The CTCAE≥2 patients 
demonstrated an increase in mean skin temperature, reaching 36.42°C at the end of treatment 
with a significant temperature increase of 0.58°C(±0.172C) from baseline (p<0.01), whereas the 
CTCAE≤1 group had an insignificant temperature increase of 0.13°C(±0.133C) compared to the 
baseline measurements (p>0.05). Figure 3C illustrates a significant difference in mean 
temperature distributions of 0.45C (±0.202C) (p=0.029) on the ipsilateral side at the 10th 
treatment fraction between CTCAE≥2 and CTCAE≤1 classes, with the CTCAE≥2 patients 
demonstrating higher breast surface temperature. 
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Thermoradiomic Markers Using Textural Features of the Treated Breast  
Most of the textural feature distributions did not demonstrate any statistical significance 
(Supplementary Figures C, D, & E). However, texture analyses identified the GLRLM-Short 
Run Emphasis (SRE) as being significantly different between the two patient groups 
(Supplementary Figure D). Thermal measurements of CTCAE≥2 patients exhibited higher 
SRE values than the CTCAE≤1 group at fx=10 (p=0.033). However, this effect demonstrates 
insignificant differences by fx=15 (p=0.69) 
 
Machine Learning Predictive Models Using Clinical Variables 
The performance of the clinical model demonstrates a prediction accuracy (Acc) of 67%, 
sensitivity (Sen) of 75% and specificity (Spec) of 57%, using the following five clinical features 
selected through a forward feature selection: adjuvant chemotherapy (y/n), type of adjuvant 
chemotherapy, radiation dose to skin volume (cGy), menopausal status, and cup size. In a second 
experiment, the forward feature selection algorithm was used to select four clinical features 
(instead of five). The selected features included adjuvant chemotherapy (y/n), radiation dose to 
skin volume (cGy), menopausal status, and cup size. The accuracy of the model in this 
experiment was 60%, with a sensitivity of 62.5% and a specificity of 57%.  
 
High-Accuracy Predictive Model for Toxicity Outcomes Using Thermoradiomic Biomarkers 
Table 2 presents the results of the skin toxicity prediction one week after the start of RT 
(at fx=5) using a select number of feature subsets. The following experiments demonstrated the 
most optimal outcome within their respective feature subsets: Experiment one (five selected 
features from first-order temperature features) demonstrated test AUC of 0.90 and test accuracy 
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of 73%; and experiment three (five selected features from all first-order temperature and texture 
features) demonstrated test AUC of 0.98 and test accuracy of 87%. The model based on 
experiment three was trained particularly well in classifying the patients in our overall analysis 
(train Acc = 91%; Sen = 0.86; Spec = 0.88). Figure 4 displays the ROC curves for experiments 
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DISCUSSION 
The aim of this study was to investigate the use of QTI biomarkers for radiation- induced 
skin toxicity in breast cancer. Our results demonstrate that patients who presented with a 
CTCAE≥2, as evaluated at the time of their last RT fraction, exhibited higher skin-surface 
temperature values during treatment compared to those who demonstrated a CTCAE≤1 score. 
The temperature differences between patient groups were most evident at the 10th fraction of 
radiotherapy. Moreover, using inferential statistical analyses alone, the QTI-texture features of 
the ipsilateral breast such as the GLRLM-SRE revealed a significant difference between the 
patient groups after the 10th radiation fraction. The CTCAE≤1 patient group showed higher 
GLRLM-SRE average values. GLRLM textural features quantitate the length/number of 
homogenic pixels, and the GLRLM-SRE is indicative of how many short lengths of homogenic 
pixels are within the matrix (31,32). Within this framework, we posit that a high GLRLM-SRE 
value in low-grade patients (CTCAE≤1) represent a finer/smoother image texture within the 
thermograms. Clinically, this corresponds to unremarkable dermatological changes and 
temperature variances on the breast skin surface (31). In contrast, patients who demonstrated a 
CTCAE≥2 had heterogeneous thermal maps of the skin, which may represent increased 
temperatures in regions of the breast that are at higher risk for dermatitis, such as the 
inframammary fold, and axilla.  
Using machine learning, we report early thermoradiomic signatures of acute skin toxicity 
which is typically observed after 10-14 days of initiating RT (33). Early thermal parameters from 
the 5th RT fraction were used in machine learning models to classify patients and to test the 
accuracy of predicting symptom-based endpoints from selected QTI and textural hybrid feature-
sets (34,35). These hybrid feature-sets, in conjunction with a nonlinear classification model and 
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bootstrapping, yielded high classification accuracy in a multidimensional space. We carried out 
several experiments, using the Random Forest method to compute individual textural features 
and temperature parameters into optimized sets that are associated with binary outcomes; i.e., 
(CTCAE≥2) versus (CTCAE≤1). Figure 4 displays the experiment containing only first-order 
feature sets and an experiment with both first-order and texture feature sets, where experiment 
three had the highest prediction accuracy and area under the ROC curve (test Acc=0.87, test 
AUC=0.98). The results presented in Figure 4 and Table 2 demonstrate the significance of using 
texture features in conjunction with the mean temperature parameter to predict skin toxicity after 
breast radiotherapy.  In comparison, the first-order temperature features alone did not 
demonstrate a high prediction accuracy (test Acc = 0.73). Despite individual QTI features that 
showed insignificant differences between groups based on a Gaussian distribution (i.e. carrying 
out inferential statistical analysis), the machine learning algorithm utilized a non-linear classifier 
to assess the predictive performance of the combined features within a multidimensional space. 
The forward feature selection method yielded optimal complementary features based on the 
relative distances of attributes within the feature space (36). We tested clinical features alone, to 
develop a baseline machine learning model. A comparison between clinical models versus 
thermoradiomic models were carried out and the results suggest that thermoradiomic markers 
demonstrate superior early-predictors of radiation- induced skin toxicity compared to using 
clinical features alone. Within these frameworks, we propose that QTI may be used as a clinical 
tool in radiation oncology; specifically, that measuring the breast surface temperature and 
extracting the associated texture features may serve as possible predictive biomarkers for severe 
radiation- induced skin toxicity (CTCAE≥2).  
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 19 
In comparison to other investigations, Templeton et al. measured radiation- induced 
dermatitis in mice using three-dimensional thermal tomography. Their results revealed an 
increase in the thermal effusivity, which was associated with high-grade skin dermatitis (37,38). 
In the clinical setting, our findings are concordant with a previous study by Maillot et al., which 
tested thermography for monitoring and predicting skin toxicity in a prospective patient cohort 
(n=64) (13). Patients in that study who demonstrated a CTCAE≥2 (i.e. high-grade dermatitis) 
showed a very significant increase in the average skin-surface temperature over the course of 
radiotherapy (p<0.001) (13). Here, our novel approach incorporated textural features from 
GLCM, GTDM, and GLRLM analyses to evaluate and predict dermatitis in breast cancer 
patients. We also employed machine- learning classification to identify early signatures (at fx=5) 
of skin toxicity, which corresponded to the patients’ CTCAE grade at the end of treatment. Other 
technologies have been used to non-invasively study radiation- induced skin toxicity. For 
example, laser doppler flowmetry (LDF) has been shown to quantitatively monitor skin toxicity 
by measuring microscopic changes in blood flow associated with skin reactions (39,40). Previous 
studies have demonstrated that the LDF microcirculation index values correspond with CTCAE 
scores, and suggest that LDF may be used to monitor radiation-induced dermatitis (41). 
Although there is interest in combining LDF with thermal imaging, QTI remains a more practical 
and economic imaging modality (39,42,43), due to readily available technology to radiation 
oncology clinics, as well as relaying practical and intuitive information about the macroscopic 
changes of the skin during RT (43).  
Radiation therapy remains a crucial component in the post-operative management of 
breast cancer. The associated side effects from treatment may affect patients’ quality of life. 
Particularly, severe skin toxicity is prevalent within this patient population and carries an 
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increased risk of pain, and discomfort. Approximately 61.9% of patients will develop CTCAE 2 
toxicity; whereas 8.3% present with CTCAE 3 symptoms after two weeks of treatment (44). In 
our patient cohort, 41.1% of patients had a CTCAE ≥ 2. Therefore, it represents a significant 
patient population that would potentially benefit from early detection and early intervention for 
symptom management. Radiation-induced skin toxicity associated with RT may be better 
managed using thermography and has several advantages such as portability, relatively low cost 
compared to other imaging devices and may provide actionable biomarkers that may guide the 
administration of early-intervention therapeutics. Therapeutic options include Mepitel film for 
prophylaxis against the onset of skin toxicity. The mechanism of action of Mepitel film involves 
protecting the affected skin from external contamination and maintaining a moist environment to 
facilitate wound healing (45–47). Herst et al. demonstrated that Safe-tac-based Mepitel film 
prevented the occurrence of radiation- induced skin toxicity by 92% (p<0.0001) and improved 
post-radiation patient satisfaction (45). Thermal imaging may also provide a method to validate 
the efficacy of pharmacological agents to manage skin toxicity (16,48). For instance, while 
glucocorticosteroids are successful in treating radiation- induced skin toxicity, their anti-
inflammatory effects have been found to interfere with passive wound healing which may 
compromise the structural integrity of the tissue in the long term (48,49). Quantitative thermal 
imaging has potential uses as a decision-support tool. QTI-based biomarkers could steer 
symptom management decisions in radiation oncology; for example, avoiding unnecessary 
treatments for patients who demonstrate a low-risk risk of developing skin symptoms. 
Conversely, for patients who have a high-risk, there is an opportunity to develop a personalized 
thermography-guided approach for skin toxicity management and prevention.  
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The limitations of this study include low sample size, which affects the framework of the 
prediction model.  First, small sample sets limit the approach for group classification (i.e. 
sufficient samples and distributions are required between classes). Second, model testing and 
validation in small sample sets have a greater risk of yielding an overfitted prediction model. To 
address this problem, the predictive model was trained using a LOPO validation approach, and 
subsequently evaluated using unseen data from an independent test set. Furthermore, while data 
collection conditions were controlled as best as possible, some inconsistencies in experimental 
conditions, such as heavy clothing attire, may have led to an increase in patients’ skin-surface 
temperature prior to imaging. We attempted to reduce this effect by instructing patients to 
change into standard hospital gowns prior to imaging. Other limitations include interfraction ROI 
selection. Although we used clinical- and protocol-guided segmentation with reference to the 
radiation treatment plan, the region of interest may also fluctuate based on anatomical changes 
(i.e. changes in the size of the breast), as well as positional differences of the patient at each time 
interval. Our study population was largely composed of Caucasian and Asian patients (86.7%) 
with light skin pigmentation (Table 1) who tend to demonstrate less severe skin toxicity than 
patients with darker skin pigmentation (50). Ethnicity is a known risk factor for radiation-
induced skin toxicity, most notably, black patients have a 73% greater risk of skin-dermatitis 
than other ethnic groups, and thus it is crucial that these methods be repeated in a patient 
population with greater diversity in ethnicity and skin phenotype (50,51).  In future work, 
thermoradiomic markers may also be useful in other cancer sites, such as head and neck (H&N) 
radiation oncology.  Severe skin toxicity, characterized as confluent moist desquamation (i.e. 
grade 3) presents in approximately 23% of H&N patients (52);  thus, early thermoradiomic 
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markers in this setting may significantly improve management strategies at the beginning of the 
seven-week treatment course for this patient population.    
In conclusion, QTI is a readily available technology, and may potentially support clinical 
decisions in breast radiation oncology. Quantitative assessments of skin toxicity are useful to 
reduce diagnostic variability among health care providers and have the potential to validate early 
clinical management of skin-related side effects of treatment. Advances to current practices are 
limited by the available imaging tools that can objectively measure skin toxicity. As a result, 
visual inspection and patient-reported symptoms remains the primary method, but may be 
subjective (7,53,54). Thermal imaging has the potential to reduce these biases and may also 
complement current grading systems, such as the CTCAE score. It could potentially help better 
define the grading scales within quantitative thermal boundaries. Image-guided radiotherapy 
already plays an integral role in the clinic for treatment delivery. This study demonstrates the 
feasibility of additional image-guided approaches; specifically, to use QTI as a clinical decision 










Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 23 
REFERENCES 
1.  Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of 
radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast 
cancer death: Meta-analysis of individual patient data for 10 801 women in 17 randomised 
trials. Lancet. 2011;378(9804):1707–16.  
2.  McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy 
after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer 
mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised 
trials. Lancet. 2014;383(9935):2127–35.  
3.  Tesselaar E, Flejmer AM, Farnebo S, Dasu A. Changes in skin microcirculation during 
radiation therapy for breast cancer. Acta Oncol (Madr). 2017;56(8):1072–80.  
4.  Chan RJ, Larsen E, Chan P. Re-examining the evidence in radiation dermatitis 
management literature: An overview and a critical appraisal of systematic reviews. Int J 
Radiat Oncol Biol Phys. 2012;84(3):e357–62.  
5.  Ryan JL. Ionizing Radiation: The Good, the Bad, and the Ugly. J Invest Dermatol 
[Internet]. 2012 Mar;132(3):985–93. Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S0022202X15356608 
6.  Wei J, Meng L, Hou X, Qu C, Wang B, Xin Y, et al. Radiation- induced skin reactions: 
mechanism and treatment. Cancer Manag Res. 2019;11:167–77.  
7.  Huang CJ, Hou MF, Luo KH, Wei SY, Huang MY, Su SJ, et al. RTOG, CTCAE and 
WHO criteria for acute radiation dermatitis correlate with cutaneous blood flow 
measurements. Breast. 2015;24(3):230–6.  
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 24 
8.  Sprangers MAG. Response-shift bias: A challenge to the assessment of patients’ quality of 
life in cancer clinical trials. Cancer Treat Rev. 1996;22(SUPPL.1):55–62.  
9.  Murray CS, Rees JL. How robust are the dermatology life quality index and other self-
reported subjective symptom scores when exposed to a range of experimental biases? Acta 
Derm Venereol. 2010;90(1):34–8.  
10.  Owen R, Ramlakhan S. Infrared thermography in paediatrics: a narrative review of 
clinical use. BMJ Paediatr Open. 2017;1(1):e000080.  
11.  Nagori A, Dhingra LS, Bhatnagar A, Lodha R. Predicting Hemodynamic Shock from 
Thermal Images using Machine Learning. Sci Rep. 2019;9(1):1–9.  
12.  Martini G. Juvenile-onset localized scleroderma activity detection by infrared 
thermography. Rheumatology. 2002 Oct;41(10):1178–82.  
13.  Maillot O, Leduc N, Atallah V, Escarmant P, Petit A, Belhomme S, et al. Evaluation of 
acute skin toxicity of breast radiotherapy using thermography: Results of a prospective 
single-centre trial. Cancer/Radiothérapie [Internet]. 2018 Apr; Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S1278321818300477 
14.  Thermography based breast cancer detection using texture features and minimum variance 
quantization. EXCLI J [Internet]. 2014 Nov [cited 2019 Apr 25];13:1204–15. Available 
from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464488/ 
15.  Ulff E, Maroti M, Serup J, Falkmer U. A potent steroid cream is superior to emollients in 
reducing acute radiation dermatitis in breast cancer patients treated with adjuvant 
radiotherapy. A randomised study of betamethasone versus two moisturizing creams. 
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 25 
Radiother Oncol. 2013;108(2):287–92.  
16.  Freedman GM. Topical Agents for Radiation Dermatitis in Breast Cancer: 50 Shades of 
Red or Same Old, Same Old? Int J Radiat Oncol. 2014;90(4):736–8.  
17.  Ulff E, Maroti M, Serup J, Nilsson M, Falkmer U. Prophylactic treatment with a potent 
corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A 
randomized double blinded study. Radiother Oncol. 2017;122(1):50–3.  
18.  Piroth MD, Piroth DM, Pinkawa M, Woodruff SG, Holy R, Eble MJ. Immediate 
Reconstruction with an Expander / Implant Following Ablatio Mammae because of Breast 
Cancer Side Effects and Cosmetic Results after Adjuvant Chest Wall Radiotherapy. 
2009;(10):669–74.  
19.  Mulliez T, Veldeman L, Greveling A Van, Speleers B, Sadeghi S, Berwouts D, et al. 
Hypofractionated whole breast irradiation for patients with large breasts : A randomized 
trial comparing prone and supine positions. Radiother Oncol. 2013;108(2):203–8.  
20.  Chen MF, Chen WC, Lai CH, Hung CH, Liu KC, Cheng YH. Predictive factors of 
radiation- induced skin toxicity in breast cancer patients. BMC Cancer. 2010 Sep;10.  
21.  Lee TF, Sung KC, Chao PJ, Huang YJ, Lan JH, Wu HY, et al. Relationships among 
patient characteristics, irradiation treatment planning parameters, and treatment toxicity of 
acute radiation dermatitis after breast hybrid intensity modulation radiation therapy. PLoS 
One. 2018 Jul;13(7).  
22.  Parekh A, Dholakia AD, Zabranksy DJ, Asrari F, Camp M, Habibi M, et al. Predictors of 
radiation- induced acute skin toxicity in breast cancer at a single institution: Role of 
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 26 
fractionation and treatment volume. Adv Radiat Oncol. 2018;3(1):8–15.  
23.  van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. 
Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 
[Internet]. 2017 Nov 1;77(21):e104–7. Available from: 
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.CAN-17-0339 
24.  Welch ML, McIntosh C, Haibe-Kains B, Milosevic MF, Wee L, Dekker A, et al. 
Vulnerabilities of radiomic signature development: The need for safeguards. Radiother 
Oncol [Internet]. 2019 Jan;130:2–9. Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0167814018335515 
25.  Haralick RM, Shanmugam K, Dinstein I. Textural Features for Image Classification. IEEE 
Trans Syst Man Cybern. 1973 Nov;3(6):610–21.  
26.  Albregtsen F. Statistical Texture Measures Computed from Gray Level Coocurrence 
Matrices. Image Processing Laboratory, Department of Informatics, University of Oslo. 
2008.  
27.  Thibault G, Fertil B, Navarro C, Pereira S, Cau P, Levy N, et al. Shape and texture 
indexes application to cell nuclei classification. Int J Pattern Recognit Artif Intell. 
2013;27(1).  
28.  Sun C, Wee WG. Neighboring gray level dependence matrix for texture classification. 
Comput Vision, Graph Image Process. 1983;23(3):341–52.  
29.  Chernick MR, Murthy VK, Nealy CD. Application of bootstrap and other resampling 
techniques: Evaluation of classifier performance. Pattern Recognit Lett. 1985;3(3):167–
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 27 
78.  
30.  He H, Garcia E. Learning from imbalanced data. IEEE Trans Knowl Data. 2009;21(9):9.  
31.  Xu D-H, Kurani AS, Furst JD, Raicu DS. Run-Length Encoding for Volumetric Texture. 
Heart. 2004;27(25):452–8.  
32.  Kolossváry M, Kellermayer M, Merkely B, Maurovich-Horvat P. Cardiac Computed 
Tomography Radiomics. J Thorac Imaging. 2018;33(1):26–34.  
33.  Porock D, Kristjanson L. Skin reactions during radiotherapy for breast cancer: The use 
and impact of topical agents and dressings. Eur J Cancer Care (Engl). 1999;8(3):143–53.  
34.  Makridakis S, Spiliotis E, Assimakopoulos V. Statistical and Machine Learning 
forecasting methods: Concerns and ways forward. PLoS One. 2018;13(3):1–26.  
35.  Bzdok D, Altman N, Krzywinski M. Points of Significance: Statistics versus machine 
learning. Nat Methods. 2018;15(4):233–4.  
36.  Lo A, Chernoff H, Zheng T, Lo SH. Why significant variables aren’t automatically good 
predictors. Proc Natl Acad Sci U S A. 2015;112(45):13892–7.  
37.  Templeton A, Chu J, Sun M, Yao R, Sun J, Coon A, et al. Thermal Effusivity Changes as 
a Precursor to Moist Desquamation. Radiat Res. 2012;178(4):295–303.  
38.  Chu J, Sun J, Templeton A, Yao R, Griem K. Thermal effusivity: A promising imaging 
biomarker to predict radiation-induced skin injuries. Health Phys. 2012;103(2):204–9.  
39.  Petersen LJ. Direct comparison of laser Doppler flowmetry and laser Doppler imaging for 
assessment of experimentally- induced inflammation in human skin. Inflamm Res. 
2013;62(12):1073–8.  
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 28 
40.  Micheels J, Aisbjorn B, Sorensen B. Laser doppler flowmetry. A new non-invasive 
measurement of microcirculation in intensive care? Resuscitation. 1984;12(1):31–9.  
41.  González Sanchis A, Brualla González L, Sánchez Carazo JL, Gordo Partearroyo JC, 
Esteve Martínez A, Vicedo González A, et al. Evaluation of acute skin toxicity in breast 
radiotherapy with a new quantitative approach. Radiother Oncol. 2017;122(1):54–9.  
42.  Burke-Smith A, Collier J, Jones I. A comparison of non-invasive imaging modalities: 
Infrared thermography, spectrophotometric intracutaneous analysis and laser Doppler 
imaging for the assessment of adult burns. Burns. 2015;41(8):1695–707.  
43.  Murray AK, Herrick AL, King TA. Laser Doppler imaging: A developing technique for 
application in the rheumatic diseases. Rheumatology. 2004;43(10):1210–8.  
44.  Drost L, Li N, Vesprini D, Sangha A, Lee J, Leung E, et al. Prospective Study of Breast 
Radiation Dermatitis. Clin Breast Cancer [Internet]. 2018 Mar; Available from: 
http://linkinghub.elsevier.com/retrieve/pii/S1526820918300065 
45.  Herst PM, Bennett NC, Sutherland AE, Peszynski RI, Paterson DB, Jasperse ML. 
Prophylactic use of Mepitel Film prevents radiation- induced moist desquamation in an 
intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiother 
Oncol. 2014;110(1):137–43.  
46.  Wooding H, Yan J, Yuan L, Chyou TY, Gao S, Ward I, et al. The effect of mepitel film on 
acute radiation-induced skin reactions in head and neck cancer patients: A feasibility 
study. Br J Radiol. 2018;91(1081).  
47.  Field CK, Kerstein MD. Overview of wound healing in a moist environment. Am J Surg. 
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 29 
1994;167(1A):2S-6S.  
48.  Yee C, Wang K, Asthana R, Drost L, Lam H, Lee J, et al. Radiation- induced Skin 
Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials. Clin 
Breast Cancer. 2018;18(5):e825–40.  
49.  Grose R, Werner S, Kessler D, Tuckermann J, Huggel K, Durka S, et al. A role for 
endogenous glucocorticoids in wound repair. EMBO Rep. 2002;3(6):575–82.  
50.  Wright JL, Takita C, Reis IM, Zhao W, Lee E, Hu JJ. Racial variations in radiation-
induced skin toxicity severity: Data from a prospective cohort receiving postmastectomy 
radiation. Int J Radiat Oncol Biol Phys. 2014;90(2):335–43.  
51.  Schnur JB, Ouellette SC, Dilorenzo TA, Green S, Montgomery GH. A qualitative analysis 
of acute skin toxicity among breast cancer radiotherapy patients. Psychooncology. 
2011;20(3):260–8.  
52.  Meyer F, Fortin A, Wang CS, Liu G, Bairati I. Predictors of Severe Acute and Late 
Toxicities in Patients With Localized Head-and-Neck Cancer Treated With Radiation 
Therapy. Int J Radiat Oncol [Internet]. 2012 Mar;82(4):1454–62. Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0360301611005414 
53.  D’haese S, Van Roy M, Bate T, Bijdekerke P, Vinh-Hung V. Management of skin 
reactions during radiotherapy in Flanders (Belgium): A study of nursing practice before 
and after the introduction of a skin care protocol. Eur J Oncol Nurs. 2010;14(5):367–72.  
54.  Chan RJ, Webster J, Chung B, Marquart L, Ahmed M, Garantziotis S. Prevention and 
treatment of acute radiation-induced skin reactions: A systematic review and meta-
Thermal Imaging of Skin Toxicity ROB-D-19-00982 , V3: Dec 11 2019 
 30 









Schematic demonstrating the workflow and methodology of the study.  
 
Figure 2 
(A) Digital image of a lumpectomy patient at baseline. (B) Thermal image representation of 
image A. (C) A schematic illustrating the area of measurement for the mean temperature values 
in both ipsilateral and contralateral breasts; (D) Digital image at the end of a 4250Gy RT 
regimen. (E) Thermal image representation of image C. (F) Skin rendition highlighting the area 
receiving radiation. (G) ROI selection based on the target area outlined in the skin rendition. (H) 
The grey-level representation of the selected ROI. Temperature scale bar: Figures B, E & G, 
Grey level scale bar: Figure H; Abbreviations: Temp.= Temperature; µ= Mean; µT= Mean 
Temperature; Avg= Average. 
 
Figure 3 
(A – B). Comparison of ipsilateral and contralateral mean temperature averages between patients 
evaluated with a CTCAE score of either ≥2 or ≤1 at baseline and at every 5th RT fraction. (C) 
Sample distribution comparison of mean temperature values between CTCAE≥2 and CTCAE≤1 
groups after 10 fractions of RT for both ipsilateral and contralateral sides. Mean temperature 
(ΔµTAvg) value differences between CTCAE≤1 and CTCAE≥2 patient groups. * = p<0.05 ** = 
P≤0.01, based on independent t-test. Error bars represent standard error of the mean.  
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Figure 4 
Test Receiver Operating Characteristic (ROC) curves for two representative experiments.  
 
